Back to results
US 2019/0375795 A1Published application
Kv1.3 potassium channel antagonists
Assigneecgtx-Peptide Development GmbH
InventorsAndreas Klostermann, Jörg Stockhaus
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds which are capable of selectively binding to and inhibiting the activity of the potassium channel Kv1.3. The invention also relates to pharmaceutical compositions comprising such compounds and to the use of said compounds and said pharmaceutical compositions for the treatment or prevention of autoimmune diseases, obesity, parodontitis and/or tissue transplant rejection.
Claims5
1-9. (canceled)
A method of inhibiting a Kv1.3 potassium channel in a subject in need thereof, comprising:
- administering a composition comprising a peptide of the sequence of SEQ ID NO:
- 25 to said subject.
Dependencies are inferred from the claim text.